Рыночные новости
Заголовки по акциям и крипте из Alpaca. Храним 7 дней. Всего: 9750.
-
Remak-Energomontaż S.A. Management Board Position on Tender OfferThe Management Board of Remak-Energomontaż S.A. has issued its official position regarding the tender offer for the company's shares initiated by Zarmen sp. z o.o.
-
Fable Media Group: Comment on guidance adjustmentRedeye Nordic Growth AB has published a research note regarding a guidance adjustment for Fable Media Group.
-
K2G Holding AG Subsidiary In-Revento Partners with ecore for MyGenny.bro LaunchK2G Holding AG's subsidiary, In-Revento, has partnered with ecore to launch the MyGenny.bro insurance comparison module, with a target of 4,000 licenses by 2029.
-
Regenbogen AG Receives Expert Valuation for Prerow Compensation ClaimRegenbogen AG announced that an independent expert has valued the structural facilities at its former Prerow camping site at 5.8 million EUR as of December 31, 2023.
-
Berentzen-Gruppe Boards Recommend Sazerac Takeover OfferThe Executive Board and Supervisory Board of Berentzen-Gruppe AG have officially recommended that shareholders accept the takeover offer from Sazerac.
-
Climeon Reports Q3 2026 Financial Results and Operational UpdatesClimeon reported its third-quarter 2026 financial results, showing a narrowed operating loss and the completion of a SEK 50 million directed share issue.
-
bet-at-home.com AG Lowers 2026 Earnings GuidanceThe company has revised its financial outlook for the 2026 fiscal year, lowering its EBITDA and gross betting and gaming revenue (GGR) expectations.
-
NuWays AG Reaffirms Buy Rating and Guidance for NanoRepro AGEquity research firm NuWays AG has reiterated its 'BUY' rating for NanoRepro AG, confirming the company's long-term sales targets.
-
ABG Sundal Collier Downgrades Coloplast to 'Sell'ABG Sundal Collier has downgraded its rating for Coloplast from 'Hold' to 'Sell', setting a new price target of 420 Danish kroner.
-
Più Medical Completes Acquisition of 60% Stake in Farmacia dell'AquilaPiù Medical S.p.A. has finalized the acquisition of a 60% controlling interest in the Italian pharmacy Farmacia dell'Aquila.
-
Artmarket.com Releases Spanish Edition of AI-Focused WorkArtmarket.com has published a complete Spanish-language edition of its 1,800-page work, "Dialogue Between a Thinker and AI," for free worldwide download.
-
Corline Biomedical Issues 2026 Financial Forecast and 2027 GuidanceCorline Biomedical AB has released a financial forecast for 2026 and provided guidance for 2027, citing recent customer orders and projections.
-
Pentixapharm Reports Progress on Pivotal Phase 3 PANDA StudyPentixapharm Holding AG has completed key preparatory work for its pivotal Phase 3 PANDA study and announced a date for its third-quarter 2026 financial results.
-
Masterflex SE Reports Record Earnings for the First Nine Months of 2026Masterflex SE announced a revenue increase and record operating earnings for the first nine months of 2026, while reaffirming its full-year guidance.
-
Cherry SE Advances Transformation Program Blossom with Restructuring and Job ReductionsCherry SE is restructuring its Peripherals business as part of its 'Blossom' transformation program, which includes a reduction in jobs to improve operational profitability.
-
PION Group Reports Significant Increase in Q3 2026 Operating ProfitPION Group AB announced a significant improvement in its operating profit for the third quarter of 2026.
-
Bilendi Reports Q3 2026 Revenue ResultsBilendi announced its revenue results for the third quarter and nine-month period ended September 30, 2026, reporting a slight return to revenue growth.
-
Sequans Communications Announces Preliminary Unaudited Third Quarter 2026 Financial ResultsSequans Communications S.A. reported preliminary unaudited financial results for the third quarter ended September 30, 2026, highlighting significant revenue growth and improved operating margins.
-
OssDsign Reports Q3 2026 Financial ResultsOssDsign AB reported a decline in third-quarter sales due to seasonal surgery disruptions, while highlighting improvements in gross margins and ongoing commercial restructuring efforts.
-
Passus S.A. Publishes Q3 2026 Consolidated Quarterly ReportPassus S.A. has released its consolidated quarterly report for the third quarter of 2026.